GDF15 and obesity due to melanocortin 4 receptor deficiency: Thus, the effectiveness of BS in reducing fat mass and resolving obesity-related comorbidities (such as T2D, HBP, or fatty liver) could lead to changes in both circulating GDF15 and its primary tissue source.